We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.13B
AUM Growth
+$319M
Cap. Flow
+$340M
Cap. Flow %
30.15%
Top 10 Hldgs %
55.39%
Holding
5,820
New
1,131
Increased
1,662
Reduced
1,677
Closed
1,185

Sector Composition

Rank Sector Weight
1 Financials 2.49%
2 Industrials 2.24%
3 Healthcare 2.07%
4 Consumer Discretionary 2.05%
5 Energy 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANGI icon
2076
Angi Inc
ANGI
$201M
$20K ﹤0.01%
320
-154
-32% -$9.46K
BLMN icon
2077
Bloomin' Brands
BLMN
$931M
$20K ﹤0.01%
921
-3,334
-78% -$75K
CEMB icon
2078
iShares JPMorgan EM Corporate Bond ETF
CEMB
$405M
$20K ﹤0.01%
399
+34
+9% +$1.71K
CRK icon
2079
Comstock Resources
CRK
$3.88B
$20K ﹤0.01%
1,177
+1,157
+5,785% +$24K
DDD icon
2080
3D Systems Corp
DDD
$588M
$20K ﹤0.01%
1,000
-1,234
-55% -$29.8K
DSM
2081
BNY Mellon Strategic Municipal Bond Fund
DSM
$291M
$20K ﹤0.01%
+2,546
New +$20.1K
DXPE icon
2082
DXP Enterprises
DXPE
$3.07B
$20K ﹤0.01%
420
-335
-44% -$14.8K
ENPH icon
2083
Enphase Energy
ENPH
$5.24B
$20K ﹤0.01%
2,568
+2,373
+1,217% +$25.8K
ERII icon
2084
Energy Recovery
ERII
$450M
$20K ﹤0.01%
7,479
+3,354
+81% +$9.83K
ETSY icon
2085
Etsy
ETSY
$7.81B
$20K ﹤0.01%
+1,450
New +$27.9K
EVH icon
2086
Evolent Health
EVH
$404M
$20K ﹤0.01%
+1,000
New +$18.6K
DMC
2087
Del Monte Corp
DMC
$1.41B
$20K ﹤0.01%
518
-513
-50% -$19.8K
MCHB
2088
Mechanics Bancorp
MCHB
$3.72B
$20K ﹤0.01%
875
-413
-32% -$8.92K
HYHG icon
2089
ProShares High Yield-Interest Rate Hedged ETF
HYHG
$186M
$20K ﹤0.01%
+275
New +$20.2K
IGI
2090
Western Asset Investment Grade Defined Opportunity Trust
IGI
$94.4M
$20K ﹤0.01%
1,006
-494
-33% -$10.3K
IPOS icon
2091
Renaissance International IPO ETF
IPOS
$11.8M
$20K ﹤0.01%
947
+848
+857% +$19.5K
IROQ
2092
DELISTED
IF Bancorp
IROQ
$20K ﹤0.01%
1,236
+936
+312% +$15.6K
JQC icon
2093
Nuveen Credit Strategies Income Fund
JQC
$705M
$20K ﹤0.01%
2,297
-5,703
-71% -$51K
KEP icon
2094
Korea Electric Power
KEP
$16B
$20K ﹤0.01%
995
-277
-22% -$5.76K
LCTX icon
2095
Lineage Cell Therapeutics
LCTX
$282M
$20K ﹤0.01%
6,766
+6,726
+16,815% +$26.1K
NEE icon
2096
NextEra Energy
NEE
$176B
$20K ﹤0.01%
800
+400
+100% +$10.2K
PALI icon
2097
Palisade Bio
PALI
$363M
0
PCH
2098
DELISTED
PotlatchDeltic
PCH
$20K ﹤0.01%
568
-414
-42% -$15.3K
SO icon
2099
Southern Company
SO
$107B
$20K ﹤0.01%
479
-4,719
-91% -$206K
TR icon
2100
Tootsie Roll Industries
TR
$2.99B
$20K ﹤0.01%
+873
New +$20.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2015 Portfolio in Review

As of Q2 2015, Tower Research Capital (TRC) held 5,820 positions worth $1.13B, up 39% from $809M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC) deployed $340M of net new capital in Q2 2015, opening 1,131 new positions and adding to 1,662 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.

By sector, the portfolio is most concentrated in Financials at 2.5% of assets, down from 4.6% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $42.4M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2015 buy was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $337M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2015 reduction was Invesco QQQ Trust, cutting an estimated $42.4M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q2 2015, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.13B portfolio in Q2 2015.
  • Tower Research Capital (TRC) opened 1,131 new positions and closed 1,185 in Q2 2015.
  • Tower Research Capital (TRC)'s portfolio value rose 39% quarter-over-quarter to $1.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.